Efficacy and Safety of Xylitol Nasal Irrigation After Functional Endoscopic Sinus Surgery
Efficacy and Safety of Xylitol Nasal Irrigation After Functional Endoscopic Sinus Surgery: A Randomized Controlled Study
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
None Selected
-
Taichung, None Selected, Taiwan, 40705
- Taichung Veterans General Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients with chronic rhinosinusitis who failed medical treatment
- Patients underwent bilateral primary functional endoscopic sinus surgery.
Exclusion Criteria:
- Patients with a history of immunodeficiency
- Patients with a history of sinus surgery
- Patients who receiving antibiotic treatment within a week before functional endoscopic sinus surgery
- Patients with a pathological diagnosis of fungal sinusitis
- Patients with a pathological diagnosis of sinonasal tumor
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: xylitol
In the xylitol group, 5% xylitol solutions were first prepared by mixing two packs of 10 mg xylitol powder with 400 mL of sterile water in the container of the irrigator.
Nasal irrigation was performed by using a Sanvic SH903 pulsatile irrigator (Yun-Wang Industrial Co., Tainan, Taiwan).
When irrigating the nose, patients irrigated both of their nasal cavities each with 200 mL of solutions once a day.
Patients performed nasal irrigations for 2 months.
|
The bilateral nasal cavity was irrigated by using a Sanvic SH903 pulsatile irrigator containing 400 ml of xylitol solution once a day for 2 months.
|
|
Placebo Comparator: saline
In the saline group, the normal saline solution was prepared by mixing 2 packs of 1.8 mg salt powder with 400 mL of sterile water in the container of the irrigator.
Nasal irrigation was performed by using a Sanvic SH903 pulsatile irrigator (Yun-Wang Industrial Co., Tainan, Taiwan).
When irrigating the nose, patients irrigated both of their nasal cavities each with 200 mL of solutions once a day.
Patients performed nasal irrigations for 2 months.
|
The bilateral nasal cavity was irrigated by using a Sanvic SH903 pulsatile irrigator containing 400 ml of normal saline once a day for 2 months.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Taiwanese version of the 22-item Sino-Nasal Outcome Test
Time Frame: From before operation to 3 months after surgery
|
The Taiwanese version of the 22-item Sino-Nasal Outcome Test contains 22 items of symptoms and social/emotional consequences from nasal disorder.
Patients are asked to rate their problems based on how they have been over the past two weeks.
Each item is graded from 0 (no problem) to 5 (as bad as it can be) according to its severity and frequency.
|
From before operation to 3 months after surgery
|
|
Self-reported adverse events
Time Frame: From before nasal irrigation to after 2-month nasal irrigation
|
Any adverse events occurring during the 2 months period of nasal irrigation
|
From before nasal irrigation to after 2-month nasal irrigation
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change of the second minimal cross-sectional area of the nasal cavity
Time Frame: From before operation to 3 months after surgery
|
The second minimal cross-sectional area of the nasal cavity was measured by acoustic rhinometry.
|
From before operation to 3 months after surgery
|
|
Change of endoscopic score
Time Frame: From before operation to 3 months after surgery
|
The endoscopic appearances were categorized into polyps (0: no polyps; 1: polyps present within the middle meatus; 2: polyps beyond the middle meatus); nasal secretion (0: no secretion; 1: clear, thin secretion; 2: thick, purulent secretion); mucosal edema; scarring; crusting; (0: absent; 1: mild; 2: severe).
The score ranged from 0 to 20 for both nostrils together.
|
From before operation to 3 months after surgery
|
|
Change of saccharine transit time
Time Frame: From before operation to 3 months after surgery
|
The saccharine transit test involved placing saccharine granules under the head of the inferior turbinate in the more severely affected nostril.
The time interval (minute) between placement of saccharine granules and sensation of sweetness in the throat was recorded.
|
From before operation to 3 months after surgery
|
|
Change of score measured by Eustachian Tube Dysfunction Patient Questionnaire
Time Frame: From before nasal irrigation to after 2-month nasal irrigation
|
Using a 7-item Eustachian Tube Dysfunction Patient Questionnaire to evaluate Eustachian tube function
|
From before nasal irrigation to after 2-month nasal irrigation
|
|
Change of Eustachian Tube function by the nine-step inflation/deflation test
Time Frame: From before nasal irrigation to after 2-month nasal irrigation
|
Failure to alter the pressure of middle ear at least 10 daPa with swallowing during any of the steps was considered ETD (tuba1 function was 'Poor').
If the equilibration was successful (observed pressure change >10 daPa) in all steps, Eustachian tube function was considered 'Good'.
|
From before nasal irrigation to after 2-month nasal irrigation
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Rong-San Jiang, MD, PhD, Taichung Veterans General Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- CF19287A
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Study Data/Documents
-
Study Protocol
Information comments: Study Data/Document can be requested from the PI.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.